login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
INVIVYD INC (IVVD) Stock News
USA
- NASDAQ:IVVD -
US00534A1025
-
Common Stock
1.22
USD
+0.12 (+10.91%)
Last: 10/1/2025, 9:01:20 PM
1.21
USD
-0.01 (-0.82%)
Pre-Market:
10/2/2025, 6:44:32 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IVVD Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
- Mentions:
CLMT
WOLF
CHEK
ADAP
...
These stocks are moving in today's after hours session
8 days ago - By: Invivyd
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
8 days ago - By: Invivyd
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
15 days ago - By: Invivyd
Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
15 days ago - By: Invivyd
Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
22 days ago - By: Benzinga
- Mentions:
ACTU
CAMP
GNPX
PMVP
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
a month ago - By: Invivyd
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
a month ago - By: Invivyd
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
a month ago - By: Invivyd
Invivyd to Participate in Upcoming Investor Conferences
a month ago - By: Invivyd
Invivyd to Participate in Upcoming Investor Conferences
a month ago - By: Invivyd
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
a month ago - By: Invivyd
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
a month ago - By: Invivyd
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
a month ago - By: Invivyd
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
a month ago - By: Invivyd
Invivyd Announces Proposed Public Offering of Common Stock
a month ago - By: Invivyd
Invivyd Announces Proposed Public Offering of Common Stock
a month ago - By: Benzinga
Demystifying Invivyd: Insights From 5 Analyst Reviews
a month ago - By: Stocktwits
Retail Chatter Surges Around Invivyd After Data Show Pemgarda Neutralizes XFG COVID-19 Variant
Please enable JavaScript to continue using this application.